BioSpace News Archive

Pennsylvania compounder prohibited from manufacturing and distributing sterile human and animal drug products

Israel Parliament Approval is Expected to Catalyze Export of Medical Cannabis; ETCH Biotrace Solution Positioned as Safe and Secure Means to Manage the Legal Supply Chain for Export

Arch Oncology, Inc., a clinical-stage immuno-oncology company focused on the discovery and development of next-generation anti-CD47 antibody therapies for cancer, today announced the initiation of a new Phase 1 clinical trial of AO-176 in select solid tumors with the first patient dosed.

Initiation of Two Norovirus Vaccine Trials Expected in 1H 2019

CARB-X, a Boston University global partnership, is awarding Recida Therapeutics of Menlo Park, CA, USA, up to $4.4 million in non-dilutive funding to develop a novel antibiotic to treat serious infections caused by Gram-negative bacteria.

Innoviva, Inc. reported financial results for the fourth quarter ended December 31, 2018.

Nordsol, the BioLNG production and technology company, has brought Shell Ventures on as strategic investor to support its mission to enable the energy transition by making BioLNG mainstream

Angie O’Donnell, executive coach and co-founder of 3D Leadership Group (http://3dleadershipgroup.com), a Boston-based leadership development firm, was recently awarded a Stand Out Volunteer and Supporter by WEST – Women in the Enterprise of Science and Technology.

Rewind Therapeutics (“Rewind”), a private Belgian biotech company developing innovative first-in-class remyelinating therapies for myelin-related diseases, today announces the appointment of leading myelin and multiple sclerosis (“MS”) experts, Professors Robin Franklin and Catherine Lubetzki, to its Scientific Advisory Board.

Recent 17 Product Launches Contributed $40 Million of Net Sales in Fiscal 2019 YTD